Brought to you by 
CooperSurgical acquires preimplantation testing company Genesis Genetics for $60mm
Apr 2016
Executive Summary
Cooper Cos. Inc.'s women's health division CooperSurgical Inc. acquired private genetic testing laboratory Genesis Genetics (preimplantation testing of embryos used during the in-vitro fertilization (IVF) process).
Deal Industry
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Laboratory Testing Services
- Services
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
- Acquisition of Private Biotech
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
CooperSurgical acquires preimplantation testing company Genesis Genetics for $60mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice